HLB Starts Rivoceranib Site Planning to Diversify Supply Chain 김진수 2025.04.01 오후 04:51 HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse] 김진수 2025.03.24 오전 08:00 HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse] 나은경 2025.03.25 오전 07:49 HLB’s NDA Rejected Again; Resubmission in May, FDA Decision by July 김새미 2025.03.23 오후 05:16 Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse] 김새미 2025.03.21 오전 08:00 CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse] 나은경 2025.03.14 오전 07:58 Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse] 김새미 2025.03.11 오전 08:10 HLB’s Liver Cancer Drug Expected to Gain Approval in Europe: When Will EMA Approval Come? 김진수 2025.02.28 오전 07:56 로딩중..
HLBPharma
HLBPharma
![HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse]](https://image.edaily.co.kr/images/photo/files/NP/S/2025/03/PS25032400143b.jpg)
![HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032500216b.jpg)
![Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032100275b.jpg)
![CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031400303b.jpg)
![Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031100284b.jpg)
